Antimicrobial Compounds from Eukaryotic Microalgae against Human Pathogens and Diseases in Aquaculture

The search for novel compounds of marine origin has increased in the last decades for their application in various areas such as pharmaceutical, human or animal nutrition, cosmetics or bioenergy. In this context of blue technology development, microalgae are of particular interest due to their immense biodiversity and their relatively simple growth needs. In this review, we discuss about the promising use of microalgae and microalgal compounds as sources of natural antibiotics against human pathogens but also about their potential to limit microbial infections in aquaculture. An alternative to conventional antibiotics is needed as the microbial resistance to these drugs is increasing in humans and animals. Furthermore, using natural antibiotics for livestock could meet the consumer demand to avoid chemicals in food, would support a sustainable aquaculture and present the advantage of being environmentally friendly. Using natural and renewable microalgal compounds is still in its early days, but considering the important research development and rapid improvement in culture, extraction and purification processes, the valorization of microalgae will surely extend in the future.

Keyword(s)

biological activity, antimicrobial, antibacterial, antifungal, antiviral, biological activity, Haslea, microalgae, sustainable aquaculture

How to cite
Falaise Charlotte, Francois Cyrille, Travers Marie-Agnes, Morga Benjamin, Haure Joel, Tremblay Rejean, Turcotte Francois, Pasetto Pamela, Gastineau Romain, Hardivillier Yann, Leignel Vincent, Mouget Jean-Luc (2016). Antimicrobial Compounds from Eukaryotic Microalgae against Human Pathogens and Diseases in Aquaculture. Marine Drugs. 14 (9). 159 (1-27). https://doi.org/10.3390/md14090159, https://archimer.ifremer.fr/doc/00349/46052/

Copy this text